Transient hyperglycemia in patients with tuberculosis in Tanzania: Implications for diabetes screening algorithms

Journal of Infectious Diseases

Volumn 213, Issue 7, 2016, Pages 1163-1172

  Boillat Blanco, Noémie ^a,e,f,g   Ramaiya, Kaushik L ^b,c   Mganga, Maliwasa ^d   Minja, Lilian T ^a   Bovet, Pascal ^h   Schindler, Christian ^e,f   Von Eckardstein, Arnold ⁱ   Gagneux, Sebastien ^e,f   Daubenberger, Claudia ^e,f   Reither, Klaus ^a,e,f   Probst Hensch, Nicole ^e,f  

^a IFAKARA HEALTH INSTITUTE   (Tanzania)

^b Shree Hindu Mandal Hospital   (Tanzania)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^d National Programme on Tuberculosis and Leprosy   (Tanzania)

^e SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^f UNIVERSITY OF BASEL   (Switzerland)

^g LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^h UNIVERSITY OF LAUSANNE   (Switzerland)

ⁱ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Diabetes mellitus; Stress induced hyperglycemia; Sub Saharan Africa; Transient hyperglycemia; Tuberculosis

Indexed keywords

HEMOGLOBIN A1C; TUBERCULOSTATIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE; ARTICLE; BODY MASS; CAPILLARY BLOOD; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCREENING TEST; SEX DIFFERENCE; SOCIAL STATUS; TANZANIA; TUBERCULOSIS; ALGORITHM; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; TIME FACTOR; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADULT; ALGORITHMS; ANTITUBERCULAR AGENTS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; TANZANIA; TIME FACTORS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84962577708     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv568     Document Type: Article

References (40)

1. Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 2011; 9:81.
2. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008; 5:e152.
3. Stevenson CR, Forouhi NG, Roglic G, et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health 2007; 7:234.
4. WHO.World Health Organization, International Union against Tuberculosis and Lung Disease: Provisional Collaborative Framework for Care and Control of Tuberculosis and Diabetes, 2011. http://whqlibdocwhoint/publications/2011/9789241502252-engpdf. Accessed April 2014.
5. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87:4-14.
6. WHO. Global Tuberculosis Report 2014. Geneva: World Health Organization, 2014.
7. Faurholt-Jepsen D, Range N, Praygod G, et al. Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania. PLoS One 2011; 6:e24215.
8. Kibirige D, Ssekitoleko R, Mutebi E, Worodria W. Overt diabetes mellitus among newly diagnosed Ugandan tuberculosis patients: a cross sectional study. BMC Infect Dis 2013; 13:122.
9. Paula AA, FalcaoMC, Pacheco AG.Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects. AIDS Res Ther 2013; 10:32.
10. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet 2009; 373:1798-807.
11. ADA. Standards of medical care in diabetes-2014. Diabetes Care 2014; 37(suppl 1): S14-80.
12. WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia, 2006.
13. WHO. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Geneva: World Health Organization, 2011.
14. Jawad F, Shera AS, Memon R, Ansari G. Glucose intolerance in pulmonary tuberculosis. J Pak Med Assoc 1995; 45:237-8.
15. Oluboyo PO, Erasmus RT. The significance of glucose intolerance in pulmonary tuberculosis. Tubercle 1990; 71:135-8.
16. Singh MM, Biswas SK, Shah A. Impaired Glucose Tolerance in Active Pulmonary Tuberculosis. Ind J Tuberc 1984; 31:118-21.
17. Tabarsi P, Baghaei P, Marjani M, Vollmer WM, Masjedi MR, Harries AD. Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: a cohort study. J Diabetes Metab Disord 2014; 13:123.
18. United Republic of Tanzania. National Tuberculosis and Leprosy Programme and Ministry of Health and Social Welfare. Manual for the Management of Tuberculosis and Leprosy. file:///C:/Users/nboillat/Downloads/ntlp%20manual%20sixth%20edition%202013pdf 2013; 6th ed.
19. WHO. Treatment of tuberculosis guidelines. 4th ed. Geneva: World Health Organization, 2010
20. WHO. The alcohol use disorders identification test, 2001. http://wwwtalking alcoholcom/files/pdfs/WHO-auditpdf; Snd ed. Accessed 3 January 2015.
21. WHO. A global brief on hypertension. World Health Day 2013. Geneva: World Health Organization, 2013.
22. Hartung CA, Brunette W, Lerer A, Tseng C, Borriello G. Open Data Kit: Building Information Services for Developing Regions International Conference on Information and Communication Technologies for Development (ICTD). London, England, December 2010.
23. WHO. Iron deficiency anemia: assessment, prevention and control. A guide for programme managers. Geneva: World Health Organization, 2001.
24. NGSP. Harmonizing hemoglobin A1c testing. List of NGSP certified methods. http://wwwngsporg/docs/methodspdf. Accessed 3 January 2015.
25. NGSP. Harmonizing hemoglobin A1c Testing. HbA1c assay interferences. http://wwwngsporg/interfasp. Accessed September 2014.
26. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in sub-Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health 2011; 11:564.
27. Swai AB, Lutale JL, McLarty DG. Prospective study of incidence of juvenile diabetes mellitus over 10 years in Dar es Salaam, Tanzania. BMJ 1993; 306:1570-2.
28. Viswanathan V, Kumpatla S, Aravindalochanan V, et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One 2012; 7:e41367.
29. Wang Q, Ma A, Han X, et al. Prevalence of type 2 diabetes among newly detected pulmonary tuberculosis patients in China: a community based cohort study. PLoS One 2013; 8:e82660.
30. Chen R, Mias GI, Li-Pook-Than J, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012; 148:1293-307.
31. Faurholt-Jepsen D, Range N, Praygod G, et al. The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania. BMC Infect Dis 2012; 12:165.
32. Singhal A, Jie L, Kumar P, et al. Metformin as adjunct antituberculosis therapy. Sci Transl Med 2014; 6:263ra159.
33. Riza AL, Pearson F, Ugarte-Gil C, et al. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol 2014; 2:740-53.
34. NCD Risk Factor Collaboration (NCD-RisC). Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 populationbased studies with 331 288 participants. Lancet Diabetes Endocrinol 2015; 3:624-37.
35. Kumpatla S, Aravindalochanan V, Rajan R, Viswanathan V, Kapur A. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India. Diabetes Res Clin Pract 2013; 102:60-4.
36. Hardikar PS, Joshi SM, Bhat DS, et al. Spuriously high prevalence of prediabetes diagnosed by HbA(1c) in young indians partly explained by hematological factors and iron deficiency anemia. Diabetes Care 2012; 35:797-802.
37. Roy CN. Anemia of inflammation. Hematology Am Soc Hematol Educ Program 2010; 2010:276-80.
38. Mwakasungula S, Schindler T, Jongo S, et al. Red blood cell indices and prevalence of hemoglobinopathies and glucose 6 phosphate dehydrogenase deficiencies in male Tanzanian residents of Dar es Salaam. Int J Mol Epidemiol Genet 2014; 5:185-94.
39. WHO. Global tuberculosis report. Geneva: World Health Organization, 2015.
40. Essack Y, Hoffman M, Rensburg M, Van Wyk J, Meyer CS, Erasmus R. A comparison of five glucometers in South Africa. JEMDSA 2009; 14:102-5.